Literature DB >> 201757

Molecular orbital studies on the mechanism of drug-receptor interaction. 2. beta-Adrenergic drugs. An approach to explain the role of the aromatic moiety.

C Petrongolo, B Macchia, F Macchia, A Martinelli.   

Abstract

The role of the aromatic moiety of beta-adrenergic drugs in the interaction with the receptor was investigated using the quantum mechanical ab initio SCF-MO-LCAO method. The structure-activity relationship was essentially discussed by analyzing the electrostatic molecular potential of three compounds which constitute meaningful portions of isoproterenol, INPEA, and doberol, the first drug having a stimulating activity and the others a blocking one. The results obtained point out the different roles played in the drug-receptor interaction by the various regions of the drugs and they also show that the aromatic moiety influences both the affinity and the intrinsic activity of the drugs. Indeed, the spatial correspondence among zones with negative potentials, which are localized on the phenyl substitutents of isoproterenol and INPEA and on the phenyl ring of doberol, could contribute to the affinity. On the other hand, the intrinsic activity of isoproterenol might be associated both with the proton-donor tendency of one phenolic OH group and with the wide zone of negative potential which spreads on a large part of the aromati moiety.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 201757     DOI: 10.1021/jm00222a021

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  A molecular modelling study of the interaction of noradrenaline with the beta 2-adrenergic receptor.

Authors:  T J Mitchell; M S Tute; G A Webb
Journal:  J Comput Aided Mol Des       Date:  1989-09       Impact factor: 3.686

Review 2.  Determinants of molecular reactivity as criteria for predicting toxicity: problems and approaches.

Authors:  H Weinstein; J Rabinowitz; M N Liebman; R Osman
Journal:  Environ Health Perspect       Date:  1985-09       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.